Earnings Call Intelligence Subscribe
Home › Call Sheets › ISRG › Q4'25
Call sheet · Q4'25

Intuitive Surgical (ISRG)

Q4'25 earnings call · held January 22, 2026 · compared with the Q3'25 call · management-credibility review
10/12
Disclosure score
6 low flags
Financial quality
Bottom line
The sleeper story is the refurbished Xi business model creating a stealth margin tailwind - they're essentially selling $0-basis inventory at 'healthy margins' while expanding TAM in ASCs and international markets. The obvious headline is solid execution with 19% revenue growth, but the real story is they're building optionality across price points. The binding constraint is Force Feedback supply, not demand - they're moving to broad launch but still cite supply limitations. Rosa's quote captures the cardiac opportunity everyone's missing: 'minimally invasive surgery with da Vinci is a better option' for the 160K addressable procedures. My view changes if China win rates don't stabilize or if My Intuitive+ renewal rates disappoint when pricing starts Q2 2026.

The 30-second version

  • SLEEPER STORY: The refurbished Xi trade is becoming a stealth margin driver hiding in plain sight
  • Cardiac clearance is the new TAM unlock everyone's ignoring
  • China competitive dynamics are accelerating faster than they're admitting

What changed this quarter

MetricQ3'25Q4'25Change
Revenue$2.51B (23% YoY)$2.87B (19% YoY)Decelerated 400 bps but beat on absolute dollars
Pro Forma EPS$2.40 (+30% YoY)$2.53 (+14% YoY)Growth rate halved but still solid absolute performance
da Vinci Procedures19% growth17% growthDecelerated 200 bps
Ion Procedures52% growth44% growthDecelerated 800 bps
System Placements (dV)427 systems532 systems+105 systems quarter-over-quarter acceleration
Pro Forma Gross Margin68.0%67.8%20 bps compression with 95 bps tariff headwind
dV5 Utilization PremiumHigher than XiOutpacing XiConsistent validation of efficiency thesis
Trade-in Volume141 transactions146 transactionsSlight acceleration in upgrade cycle
Operating Cash Flow$736M (Q3)$2.5B full year (+92% YoY)Massive cash generation improvement
U.S. After-Hours ProceduresStrong growth+35% growthAccelerating acute care adoption

Accountability tracked

7 new promises made5 narrative shifts flagged7 prior promises scored
Inside the full report
The complete write-up covers the full promise ledger with kept/missed calls, disclosure-quality scoring, the metrics-vanished check, verification items, and the questions to ask next quarter.
Read the full ISRG Q4'25 report Subscribe
About Research ↗Call SheetsCredibility IndexMissed PromisesScreens13F BooksData & InstitutionalPrivacyTermsSubscribe
This is a free preview. The full write-up and promise ledger are published to subscribers on Substack.
Scores, kept-promise rates, and flags on this site reflect the author's opinion, applying a stated methodology to statements management made on public earnings calls. Informational and educational purposes only - not investment advice, a recommendation, or an offer to buy or sell any security. Sources believed reliable but not guaranteed; the author may hold positions in the securities discussed.

Follow what management promises next

Get free previews of our earnings-call research: the key changes, management scores, and questions worth investigating. Subscribe for full call sheets and deeper analysis.

Subscriptions are managed by Substack. If the form does not load, subscribe directly. Or follow the RSS feed.